InvestorsHub Logo
Followers 218
Posts 38765
Boards Moderated 0
Alias Born 04/29/2008

Re: Value_Investor post# 311

Saturday, 08/20/2016 7:29:46 PM

Saturday, August 20, 2016 7:29:46 PM

Post# of 432
Yeah, it was a paint at the end of the day. Typical of many stocks heading into a weekend. It will be back down on Monday.

The stock is undervalued based on liquidation, but for whatever reason, the company decided to throw it's large cash reserve into acquiring another bio tech which needs cash. And all they get is 20% of the company for that cash. That values KalVista at about $175 million, which clearly the market thinks is too high.
Based on CBYL's current price, the market values KalVista at about $70 million.

Definitely not zero risk as KalVista is just starting its phase 1 clinical trials on their one drug and results won't be announced until Q2 2017.

TA - Over $500 million in toxic funded pump and dumps exposed and growing every day!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KALV News